Debt instrument, exit fee Debt Instrument, Exit Fee Debt Instrument, Exit Fee Option Indexed to Issuer's Equity, Type [Axis] Option Indexed to Issuer's Equity, Type [Axis] Weighted average remaining contractual term, vested or expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Adjustments to reconcile net loss to net cash used for operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Repayments of long-term debt Repayments of Long-Term Debt Remaining authorized amount Share Repurchase Program, Remaining Authorized, Amount Cover [Abstract] Cover [Abstract] Net increase (decrease) in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Measurement Input, Discount Rate Measurement Input, Discount Rate [Member] Schedule of Operating Lease Liabilities Maturities Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Inventory Deferred Tax Assets, Inventory Income Tax Jurisdiction [Domain] Income Tax Jurisdiction [Domain] Trading Symbol Trading Symbol Notes payable, net Notes payable, net Long-Term Debt and Lease Obligation Number of guaranteed royalty payments Number Of Guaranteed Royalty Payments Number Of Guaranteed Royalty Payments Non-NEOs Non-NEOs [Member] Royalty Obligation Activity Royalty Obligation Activity [Table Text Block] Royalty Obligation Activity Market Condition Range Two Market Condition Range Two [Member] Market Condition Range Two Line of Credit Facility [Table] Line of Credit Facility [Table] Computer, network equipment and software Computer, Network Equipment and Software [Member] Assets which are related to computer, network equipment and software. Per Share Data Earnings Per Share, Policy [Policy Text Block] Inventories Inventory, Policy [Policy Text Block] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Financial Instruments – Fair Value Measurements Fair Value Disclosures [Text Block] Proceeds from exercise of stock options Proceeds from Stock Options Exercised Award Timing Disclosures [Line Items] Proceeds from issuance of common stock under public equity offering-ATM, net Proceeds From Issuance Of Public Offering, Issuance Of Warrants and Warrant Exercises Proceeds From Issuance Of Public Offering, Issuance Of Warrants and Warrant Exercises Gain (loss) on disposition of intangible assets Gain (Loss) on Disposition of Intangible Assets Underwritten Public Offering Underwritten Public Offering [Member] Underwritten Public Offering Pending claim Loss Contingency, Pending Claims, Number Senior Secured Notes Due 2025 - First Additional Offering First Additional Offering [Member] The first additional offering of the loan agreement. Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Segment Information Segment Reporting, Policy [Policy Text Block] Orphan Drug and R&D Tax Credits Deferred Tax Assets, Tax Credit Carryforwards Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Plan Name [Domain] Plan Name [Domain] Sale of stock, (in USD per share) Sale of Stock, Price Per Share United States UNITED STATES Other non-current assets Total other non-current assets Other Assets, Noncurrent Leases [Abstract] Intangible assets, gross Finite-Lived Intangible Assets, Gross Deferred Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Section 174 R&D Capitalization Deferred Tax Assets, Tax Credit Carryforwards, Research Receivable Type [Axis] Receivable Type [Axis] Net cash used for operating activities Net Cash Provided by (Used in) Operating Activities Research and development, costs capitalized Research and Development, Costs Capitalized Research and Development, Costs Capitalized Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Debt Covenant, Redemption Scenario [Axis] Debt Covenant, Redemption Scenario [Axis] Debt Covenant, Redemption Scenario Property and Equipment Deferred Tax Assets, Property, Plant and Equipment Costs of common stock issued under public equity offering Adjustments to Additional Paid in Capital, Stock Issued, Own-share Lending Arrangement, Issuance Costs Accretion Asset Retirement Obligation, Accretion Expense Net loss Stockholders' Equity, Other indivor indivor [Member] indivor Award Timing Method Award Timing Method [Text Block] Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Exercisable at end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Employee Benefit Plans Defined Contribution Plan [Text Block] Number of annual royalty payments receivable Number Of Annual Royalty Payments Receivable Number of annual royalty payments receivable by the entity for the use of its rights and property by another party. Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Insider Trading Policies and Procedures [Line Items] Private equity Private equity [Member] Private equity Use of Estimates Use of Estimates, Policy [Policy Text Block] Adjustment to Compensation, Amount Adjustment to Compensation Amount Payables and Accruals [Abstract] Payables and Accruals [Abstract] Compensation Amount Outstanding Recovery Compensation Amount Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Entity Small Business Entity Small Business Accrued Expenses Accounts Payable and Accrued Liabilities Disclosure [Text Block] Company Selected Measure Amount Company Selected Measure Amount ABL Facility ABL Facility [Member] ABL Facility Tabular List, Table Tabular List [Table Text Block] Employee retention tax credit, refund Income Tax Examination, Employee Retention Tax Credit, Refund Income Tax Examination, Employee Retention Tax Credit, Refund Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Market Condition Range Five Market Condition Range Five [Member] Market Condition Range Five Schedule of Other Assets, Noncurrent Schedule of Other Assets, Noncurrent [Table Text Block] Accrued expenses Total accrued expenses Accrued Liabilities, Current Dilutive securities excluded (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Fair value of warrants issued Adjustments to Additional Paid in Capital, Fair Value of Warrants Issued Amount of increase in additional paid in capital (APIC) resulting from the issuance of fair value of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants. Impairment of Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Credit Facility [Domain] Credit Facility [Domain] Accrued distribution expenses and sales returns provision Accrued Marketing Costs, Current Accounts and Financing Receivables [Table] Accounts and Financing Receivables [Table] Permanent differences Effective Income Tax Rate Reconciliation, Permanent Differences, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to permanent differences. Allowance for doubtful accounts Less: allowance for credit losses Balance at beginning of the period Balance at end of the period Accounts Receivable, Allowance for Credit Loss Payments for taxes on share-based compensation Payment, Tax Withholding, Share-Based Payment Arrangement 2020 Additional Notes 2020 Additional Notes [Member] 2020 Additional Notes Inventories, Net Inventory Disclosure [Text Block] Amended Equity Distribution Agreement Amended Equity Distribution Agreement [Member] Amended Equity Distribution Agreement Black-Scholes Black-Scholes [Member] Black-Scholes Current Current Federal, State and Local, Tax Expense (Benefit) [Abstract] Stock Options Share-Based Payment Arrangement, Option [Member] Depreciation and amortization Depreciation 2025 Lessee, Operating Lease, Liability, to be Paid, Year One Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Security, Excluded EPS Calculation [Table] Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Other Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Award Type [Axis] Award Type [Axis] Number of equity instruments Debt Instrument, Convertible, Number of Equity Instruments Property and equipment, net Total property and equipment, net Property, Plant and Equipment, Net Repayment of debt principal including lease liabilities Retirement of debt Repayments of Debt ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Total liabilities Liabilities Common stock, par or stated value per share (in dollars per share) Common Stock, Par or Stated Value Per Share Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Expiration Date Trading Arrangement Expiration Date Number of uncertain tax positions Number of Uncertain Tax Positions Number of Uncertain Tax Positions Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Proprietary product revenue, net Proprietary Product Revenue [Member] The aggregate revenue generated from proprietary product sales. Lease liabilities, current Operating Lease, Liability, Current Total Shareholder Return Amount Total Shareholder Return Amount Redemption Scenario 1 Redemption Scenario 1 [Member] Redemption Scenario 1 Summary of Restricted Stock Units Nonvested Restricted Stock Shares Activity [Table Text Block] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Additions Asset Retirement Obligation, Liabilities Incurred NOL carryforwards Deferred Tax Assets, Operating Loss Carryforwards Carl Kraus [Member] Carl Kraus Income Tax Disclosure [Line Items] Income Tax Disclosure [Line Items] Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Subsequent Event [Line Items] Subsequent Event [Line Items] Agreement term (in months) Agreement Term Agreement Term Property and equipment, gross Property, Plant and Equipment, Gross Options, exercises (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Debt Instrument [Line Items] Debt Instrument [Line Items] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Research and development Research and Development Expense [Member] Senior Secured Notes, 13.5% due November 1, 2028 Senior Secured Notes, 13.5% due November 1, 2028 [Member] Senior Secured Notes, 13.5% due November 1, 2028 Diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Total stockholders’ deficit Beginning balance Ending balance Equity, Attributable to Parent Deferred tax assets Deferred Tax Assets, Gross Proceeds from issuance of debt Proceeds from Issuance of Debt Material Agreements Collaborative Arrangement Disclosure [Text Block] Litigation Case [Axis] Litigation Case [Axis] Mitsubishi Tanabe Pharma America, Inc And Haisco For Exarvan Mitsubishi Tanabe Pharma America, Inc And Haisco For Exarvan [Member] Mitsubishi Tanabe Pharma America, Inc And Haisco For Exarvan Research and development project duration Research and Development Project Duration Research and Development Project Duration Concentration Risk Type [Domain] Concentration Risk Type [Domain] Reclassifications Accounts Receivable, Allowance for Credit Loss, Reclassifications Accounts Receivable, Allowance for Credit Loss, Reclassifications Selling, general and administrative Selling, general and administrative Selling, General and Administrative Expense Minimum royalty receivable Minimum Annual Royalty Receivable Minimum Annual Royalty Receivable Defined contribution plan, cost Defined Contribution Plan, Cost Sale of Stock [Domain] Sale of Stock [Domain] Document Fiscal Period Focus Document Fiscal Period Focus 2028 Long-Term Debt, Maturity, Year Four All Executive Categories All Executive Categories [Member] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Weighted average remaining contract life Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Assets Assets [Abstract] Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Document Type Document Type Effective annual interest rate Debt Instrument, Interest Rate, Effective Percentage License & Supply Agreement License & Supply Agreement [Member] License & Supply Agreement Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Warrants Warrants Disclosure [Text Block] The entire disclosure for warrants. Basis of Presentation and Principles of Consolidation Basis of Accounting [Text Block] Other income (expenses): Other Income and Expenses [Abstract] Exercise prices (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price Subsequent Event [Table] Subsequent Event [Table] Costs of common stock issued under public equity offering-ATM Stock Issued During Period, Value, Costs Of Registering Common Stock Related To Warrants Stock Issued During Period, Value, Costs Of Registering Common Stock Related To Warrants Maximum Maximum [Member] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Supplemental Agreement with Indivior Supplemental Agreement with Indivior [Member] The supplemental commercial exploitation agreement with Indivior. Furniture and fixtures Furniture and Fixtures [Member] Intangible assets, net Intangible assets, net Finite-Lived Intangible Assets, Net Antidilutive Securities [Axis] Antidilutive Securities [Axis] Interest expense related to royalty obligations, net Royalty Expense Accounts payable Accounts Payable, Current Summary of Stock Option Valuation Assumptions Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Statistical Measurement [Axis] Statistical Measurement [Axis] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Net loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Name Outstanding Recovery, Individual Name Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Variable lease expense Variable Lease, Cost Title and Position [Axis] Title and Position [Axis] Royalty obligations, current Royalty obligations, current Royalty Obligations, Liability, Current Royalty Obligations, Liability, Current Award Timing Predetermined Award Timing Predetermined [Flag] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Repurchase price percentage Debt Instrument, Redemption Price, Percentage Diluted (in dollars per share) Earnings Per Share, Diluted Deferred income, revenue recognized Deferred Income, Revenue Recognized Counterparty Name [Domain] Counterparty Name [Domain] Revenue Recognition Revenue from Contract with Customer [Policy Text Block] State and Local Jurisdiction State and Local Jurisdiction [Member] Costs and expenses: Cost of Goods and Services Sold [Abstract] Market Condition Range Four Market Condition Range Four [Member] Market Condition Range Four Total Current Income Tax Expense (Benefit) Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Weighted average remaining contractual term, exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Intangible Assets Intangible Assets, Finite-Lived, Policy [Policy Text Block] Retirement Benefits [Abstract] Retirement Benefits [Abstract] Debt instrument, redemption price, percentage of principal amount redeemed Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed Customer [Axis] Customer [Axis] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Income taxes benefit (expense) Provision for Income Tax Income Tax Expense (Benefit) License Agreement with Sunovion Pharmaceuticals, Inc. Upfront License Agreement with Sunovion Pharmaceuticals, Inc. Upfront [Member] The license agreement made with sunovion pharmaceuticals, inc. advance payments. Forfeited and Expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Weighted average recognition period Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Revenues Total revenues Revenues Revenue from Contract with Customer, Excluding Assessed Tax Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Interest limitation imposed by the TJCA Tax Cuts and Jobs Act of 2017, Deferred Tax Assets, Interest Limitation Amount of interest limitation for remeasurement of deferred tax asset from change in tax rate pursuant to Tax Cuts and Jobs Act of 2017. Net cash used for investing activities Net Cash Provided by (Used in) Investing Activities Income Tax Jurisdiction [Axis] Income Tax Jurisdiction [Axis] Lincoln Park Agreement Lincoln Park Agreement [Member] Lincoln Park Agreement All Adjustments to Compensation All Adjustments to Compensation [Member] Accrued compensation Employee-related Liabilities, Current Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Additional paid-in capital Additional Paid in Capital Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Severance liability Severance Cost, Liability Severance Cost, Liability Trade Accounts Receivable, Sales Related Trade Accounts Receivable, Sales Related [Member] Trade Accounts Receivable, Sales Related Debt Covenant, Redemption Scenario [Domain] Debt Covenant, Redemption Scenario [Domain] Debt Covenant, Redemption Scenario [Domain] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Entity Address, State or Province Entity Address, State or Province Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Royalty obligations Royalty Obligations, Gross Royalty Obligations, Gross Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Unvested, balance at beginning of period (in dollars per share) Unvested, balance at end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Liabilities and stockholders’ deficit Liabilities and Equity [Abstract] Valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Risks and Uncertainties [Abstract] Risks and Uncertainties [Abstract] Restatement Determination Date Restatement Determination Date Expected to vest (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Royalty obligations, net Royalty Obligations, Net Royalty Obligations, Net Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Number of shares reserved for issuance (in shares) Number of Shares Reserved for Issuance The number of shares which are reserved for issuance. Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Outstanding at beginning of period (in dollars per share) Outstanding at end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Costs of common stock issued under public equity offering-ATM Adjustments to Additional Paid in Capital, Warrant Exercised Adjustments to Additional Paid in Capital, Warrant Exercised Concentration Risk [Table] Concentration Risk [Table] Right-of-use assets, net Operating Lease, Right-of-Use Asset Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Outstanding at beginning of period (in shares) Outstanding at end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Measurement Input, Probability Of Success Measurement Input, Probability Of Success [Member] Measurement Input, Probability Of Success Net Loss Per Share Earnings Per Share [Text Block] Shares issued under employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Subsequent Event Subsequent Event [Member] Sale of Future Revenue Sale of Future Revenue [Text Block] Sale of Future Revenue Options exercised, net Stock Issued During Period, Value, Stock Options Exercised Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Packaging material Inventory Packing Material Gross Amount of packaging materials expected to be sold within one year or operating cycle, if longer. Income Taxes Income Tax, Policy [Policy Text Block] Non-cash financing activities: accrued taxes on share-based compensation Share-Based Compensation, Accrued Taxes Share-Based Compensation, Accrued Taxes Weighted-average number of common shares outstanding: Earnings Per Share, Basic, Other Disclosure [Abstract] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Segments [Domain] Segments [Domain] Discount rate Lessee, Operating Lease, Discount Rate Key Employees Executive Officer [Member] PEO PEO [Member] Other Non-Current Liabilities Asset Retirement Obligation Disclosure [Text Block] Name Trading Arrangement, Individual Name Issuance [Domain] Issuance [Domain] Issuance [Domain] Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Entity Public Float Entity Public Float Operating lease, remaining lease term Lessee, Operating Lease, Remaining Lease Term Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Balance (in shares) Balance (in shares) Shares, Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Performance price threshold, vesting percentage Share Based Compensation, Arrangement by Share-Based Payment, Market Condition, Performance Price Threshold, Vesting Percentage Share Based Compensation, Arrangement by Share-Based Payment, Market Condition, Performance Price Threshold, Vesting Percentage Local Phone Number Local Phone Number Valuation Allowance Valuation allowance Deferred Tax Assets, Valuation Allowance Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Other Non-Current Assets Other Assets Disclosure [Text Block] ATM Facility ATM Facility [Member] ATM Facility Weighted Average Remaining Contractual Term in Years Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] PEO Total Compensation Amount PEO Total Compensation Amount Employee stock purchase plan, purchase price percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Schedule of Significant Unobservable Inputs used in Initial Fair Value Measurement of the Royalty Right Agreement Schedule of Significant Unobservable Inputs Used In The Initial Fair Value Measurement Of The Royalty Right Agreement [Table Text Block] Schedule of Significant Unobservable Inputs Used In The Initial Fair Value Measurement Of The Royalty Right Agreement Statement of Income Location, Balance [Axis] Statement of Income Location, Balance [Axis] Interest payable Interest Payable, Current Vested or expected to vest at end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Debt Disclosure [Abstract] Debt Disclosure [Abstract] Royalty payment term Royalty Obligation, Term Royalty Obligation, Term Common Stock Common Stock [Member] Redemption Scenario 2 Redemption Scenario 2 [Member] Redemption Scenario 2 Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Segment Reporting [Abstract] Accounts receivable Deferred Tax Assets, Accounts Receivable Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accounts receivable. Entity Central Index Key Entity Central Index Key Return to provision Effective Income Tax Rate Reconciliation, Tax Credit, Return to Provision, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to return to provision tax credit. Selling, general and administrative General and Administrative Expense [Member] Contingent consideration, milestone payments Contingent Consideration, Milestone Payments Contingent Consideration, Milestone Payments Inventory, net Schedule of Inventory, Current [Table Text Block] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Segment Reporting Segment Reporting Disclosure [Text Block] Contract and other receivables Other Receivables, Gross, Current License Agreement with Sunovion Pharmaceuticals, Inc. License Agreement with Sunovion Pharmaceuticals, Inc. [Member] The license agreement made with sunovion pharmaceuticals, inc. Vested restricted stock units, net APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Gain on contract termination Gain on contract termination Gain (Loss) on Contract Termination Common stock issued upon warrant exercises (in shares) Stock Issued During Period, Shares, Warrants Exercised Stock Issued During Period, Shares, Warrants Exercised Title Trading Arrangement, Individual Title Unsecured Debt Unsecured Debt [Member] Unusual Risk or Uncertainty [Line Items] Unusual Risk or Uncertainty [Line Items] City Area Code City Area Code Current liabilities: Liabilities, Current [Abstract] Auditor Location Auditor Location State rate change Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent Share-based compensation expense APIC, Share-Based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Debt instrument, redemption price, basis points above treasury rate Debt Instrument, Redemption Price, Basis Spread On Variable Rate Debt Instrument, Redemption Price, Basis Spread On Variable Rate Notes payable, long-term Long-Term Debt, Excluding Current Maturities Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Weighted Average Grant Date Fair Value Per Share Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Assertio Holdings, Inc Assertio Holdings, Inc [Member] Assertio Holdings, Inc Subsequent Event Type [Axis] Subsequent Event Type [Axis] Collaborative Arrangement, Revenue Not from Contract with Customer, Statement of Income or Comprehensive Income [Extensible Enumeration] Collaborative Arrangement, Revenue Not from Contract with Customer, Statement of Income or Comprehensive Income [Extensible Enumeration] Company Overview and Equity Transactions Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Additional Warrants Additional Warrants [Member] Additional Warrants Loss per share attributable to common stockholders: Earnings Per Share [Abstract] Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Forfeited and Expired (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Inventories Increase (Decrease) in Inventories Line of credit facility, accordion feature, increase limit Line of Credit Facility, Accordion Feature, Increase Limit Line of Credit Facility, Accordion Feature, Increase Limit Debt issuance costs gross Debt Issuance Costs, Gross General and Administrative Expense General and Administrative Expense Schedule of Debt Schedule of Debt [Table Text Block] 2026 Long-Term Debt, Maturity, Year Two Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Equity Awards Adjustments Equity Awards Adjustments [Member] Total operating lease liabilities Operating Lease, Liability Debt instrument, fee amount Debt Instrument, Fee Amount Underlying Securities Award Underlying Securities Amount Premium paid to retire debt Consent fee payment Payment for Debt Extinguishment or Debt Prepayment Cost Sales of Royalty Rights Deferred Tax Asset, Royalty Obligations Deferred Tax Asset, Royalty Obligations Amendment Flag Amendment Flag Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Sale of stock, maximum transaction amount Sale of Stock, Maximum Transaction Amount Sale of Stock, Maximum Transaction Amount Machinery Machinery and Equipment [Member] Subsequent Events [Abstract] Royalty obligations, net Royalty Obligation, Liability, Noncurrent Royalty Obligation, Liability, Noncurrent Number of shares issued in transaction (in shares) Sale of Stock, Number of Shares Issued in Transaction Long-Term Debt Debt Disclosure [Text Block] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Suboxone Produce Liability Litigation Suboxone Produce Liability Litigation [Member] Suboxone Produce Liability Litigation Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Principal amount Debt Instrument, Face Amount Purchased intangible Technology-Based Intangible Assets [Member] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Common stock entitled to purchasers by pre-funded warrants (in shares) Shares of Common Stock Entitled to Purchasers by Pre-funded Warrants Shares of Common Stock Entitled to Purchasers by Pre-funded Warrants Liability Related to the Sale of Future Revenue Sale of Future Revenue [Policy Text Block] Sale of Future Revenue Common Stock Warrants Common Stock Warrants [Member] Common Stock Warrants Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Auditor Name Auditor Name Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Raw material Inventory, Raw Materials, Gross Loss on the extinguishment of debt Loss on the extinguishment of debt Gain (Loss) on Extinguishment of Debt Proceeds from sale of future revenues, net Proceeds From Sale of Future Revenues, Net Proceeds From Sale of Future Revenues, Net Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Trade receivables, period for credit term Credit Term of Trade Receivables Term of trade receivables depending on the customer and type of invoice in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Redemption percentage of debt under change of control provisions Redemption percentage of debt under change of control provisions Redemption percentage of debt under change of control provisions. Useful Lives Property, Plant and Equipment, Useful Life Subsidiary or equity method investee, cumulative percentage ownership limitation after all transactions Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership Limitation After All Transactions Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership Limitation After All Transactions Number of Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Employee Stock Purchase Plan Employee Stock [Member] Depreciation, amortization, and impairment Depreciation, Depletion and Amortization, Nonproduction Accounts payable Increase (Decrease) in Accounts Payable Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Deferred Revenue Deferred Tax Assets, Deferred Income Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Total assets Assets Manufacture and supply Cost of Goods and Services Sold Cash and cash equivalents: Cash and Cash Equivalents [Abstract] Capital expenditures Payments to Acquire Property, Plant, and Equipment Other non-current liabilities Other Liabilities, Noncurrent CLA KemPharm Zevra Therapeutics [Member] Zevra Therapeutics Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Contingencies (Note 23) Commitments and Contingencies Share-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Schedule of Income Tax Benefit Reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Termination Date Trading Arrangement Termination Date Royalty Monetization Deferred Tax Assets, Sale Of Future Revenue Deferred Tax Assets, Sale Of Future Revenue Less: sales-related allowances Accounts Receivable Allowances and Accruals - Trade and Other Receivables, Net For an unclassified balance sheet, a valuation of sales allowance for receivables due a company that are expected to be uncollectible, classified within trade and other receivables, net. Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] OID and Deferred Financing Cost Deferred Tax Assets, OID and Deferred Financing Cost Deferred Tax Assets, OID and Deferred Financing Cost 2026 Lessee, Operating Lease, Liability, to be Paid, Year Two 2025 Long-Term Debt, Maturity, Year One Liability related to the sale of future revenue, current Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Current Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Current Fair value of warrants Warrants Not Settleable in Cash, Fair Value Disclosure Proceeds from collaborators Proceeds from Collaborators Debt Instrument [Axis] Debt Instrument [Axis] Revenue from collaborative arrangement, excluding from revenue from contract with customer Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer Net loss Net loss Net loss Net Income (Loss) Attributable to Parent Trading Arrangement: Trading Arrangement [Axis] Amortization of debt discount Amortization of Debt Discount (Premium) Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Entity File Number Entity File Number Income Statement [Abstract] Income Statement [Abstract] Entity Address, Address Line One Entity Address, Address Line One Federal Current Federal Tax Expense (Benefit) Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Extinguishment of debt, amount Extinguishment of Debt, Amount Atnahs Pharma UK Limited Atnahs Pharma UK Limited [Member] Atnahs Pharma UK Limited Accrued expenses and other liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Name Forgone Recovery, Individual Name Underwriting discounts Sale of Stock, Consideration Received On Transaction, Underwriting Discounts Sale of Stock, Consideration Received On Transaction, Underwriting Discounts Other, net Other Noncash Income (Expense) Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Deferred tax liabilities: Components of Deferred Tax Liabilities [Abstract] Deferred revenue Increase (Decrease) in Deferred Revenue Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Contract with customer, asset, after allowance for credit loss Contract with Customer, Asset, after Allowance for Credit Loss Performance price threshold, per share (in dollars per share) Share Based Compensation, Arrangement by Share-Based Payment, Market Condition, Performance Price Threshold, Per Share Share Based Compensation, Arrangement by Share-Based Payment, Market Condition, Performance Price Threshold, Per Share Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Warrants and rights outstanding Warrants and Rights Outstanding Cost, Product and Service [Extensible Enumeration] Cost, Product and Service [Extensible Enumeration] Adjustment to Compensation: Adjustment to Compensation [Axis] Receivables Accounts Receivable [Member] Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Litigation Case [Domain] Litigation Case [Domain] Payments of loan costs Payments of Loan Costs Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Mitsubishi Tanabe Pharma America, Inc Mitsubishi Tanabe Pharma America, Inc [Member] Mitsubishi Tanabe Pharma America, Inc AQST-108 project expenses AQST-108 [Member] AQST-108 Basic (in shares) Weighted Average Number of Shares Outstanding, Basic Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Personnel costs Personnel Costs [Member] Personnel Costs Subsidiary, Sale of Stock [Line Items] Subsidiary, Sale of Stock [Line Items] Amortization of debt issuance costs and discounts Amortization of Debt Issuance Costs and Discounts Sale of stock, aggregate offering price Sale of Stock, Aggregate Offering Price Sale of Stock, Aggregate Offering Price Name Awards Close in Time to MNPI Disclosures, Individual Name Construction in progress Construction in Progress [Member] Revenue Revenue Benchmark [Member] Litigation settlement, amount awarded from other party Litigation Settlement, Amount Awarded from Other Party Depreciation expense related to ARO Asset Retirement Obligations Depreciation Expense Depreciation expense of asset retirement obligation. Entity Filer Category Entity Filer Category Atnahs Pharma UK Limited, Amended Agreement Atnahs Pharma UK Limited, Amended Agreement [Member] Atnahs Pharma UK Limited, Amended Agreement Loss Contingencies [Line Items] Loss Contingencies [Line Items] Stock to be purchased by common stock warrants (in shares) Shares of Common Stock to be Purchased by Common Stock Warrants Shares of Common Stock to be Purchased by Common Stock Warrants Statistical Measurement [Domain] Statistical Measurement [Domain] Interest income and other income, net Interest And Other Income, Net Interest And Other Income, Net Director Director [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] All Trading Arrangements All Trading Arrangements [Member] Royalty receivable Cumulative Royalty Receivable Cumulative sum of the carrying amounts of royalty receivable as of the balance sheet date. Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract] Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Cash payments for income taxes Income Taxes Paid, Net Summary of Share-Based Compensation Expense Share-Based Payment Arrangement, Cost by Plan [Table Text Block] Stock issued during period, conversion of convertible securities (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Pay vs Performance Disclosure [Line Items] Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Other Performance Measure, Amount Other Performance Measure, Amount Right-of-Use Assets and Lease Obligations Lessee, Operating Leases [Text Block] Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Elective redemption percentage of debt Elective redemption percentage of debt Elective redemption percentage of debt. Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Lease cost Operating Lease, Cost Pre-Funded Warrants Pre-Funded Warrants [Member] Pre-Funded Warrants Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Shares available for grant (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Lease liabilities Operating Lease, Liability, Noncurrent Deferred revenue, current Contract with Customer, Liability, Current Market Conditions [Domain] Market Conditions [Domain] Market Conditions [Domain] Indivior Indivior [Member] Indivior Entity Tax Identification Number Entity Tax Identification Number Number of payments made Debt Instrument, Number Of Payments Made Debt Instrument, Number Of Payments Made Intangible Asset, Finite-Lived [Table] Intangible Asset, Finite-Lived [Table] Asset Retirement Obligation, Roll Forward Analysis [Roll Forward] Asset Retirement Obligation, Roll Forward Analysis [Roll Forward] Offering period term Share-Based Compensation Arrangement By Share-Based Payment Award, Stock Plan Offering Period Share-Based Compensation Arrangement By Share-Based Payment Award, Stock Plan Offering Period Purchased patent Patents [Member] Consideration received on sale of stock Sale of Stock, Consideration Received on Transaction Liability related to the sale of future revenue, net at beginning of the period Liability related to the sale of future revenue, net at end of the period (includes current portion of $1,000 and $922, respectively) Liabilities, Sale of Future Royalties Liabilities, Sale of Future Royalties Premium on early retirement of debt Premiums Paid, Early Retirement of Debt Premiums Paid, Early Retirement of Debt Real estate and personal property taxes Taxes Payable, Current Royalty interest percent interest Royalty Obligation, Percent Of Net Sales Royalty Obligation, Percent Of Net Sales Plan Name [Axis] Plan Name [Axis] Equity Components [Axis] Equity Components [Axis] Research and Development Research and Development Expense, Policy [Policy Text Block] Trade Accounts Receivable Accounts Receivable [Policy Text Block] Deferred tax liabilities: Deferred Tax Liabilities, OID and Deferred Financing Cost Deferred Tax Liabilities, OID and Deferred Financing Cost Total costs and expenses Costs and Expenses Warrants issued to purchase common stock (in shares) Class Of Warrant Or Right Warrants Issued During Period The number of warrants issued during the period. Receivable [Domain] Receivable [Domain] Geographical [Axis] Geographical [Axis] Performance price threshold, vesting percentage limit Share Based Compensation, Arrangement by Share-Based Payment, Market Condition, Performance Price Threshold, Vesting Percentage Limit Share Based Compensation, Arrangement by Share-Based Payment, Market Condition, Performance Price Threshold, Vesting Percentage Limit Automatic renewal period of agreement Automatic Renewal Period of Agreement Period for which the agreement is renewed automatically. 2029 and thereafter Lessee, Operating Lease, Liability, to be Paid, Year Five Trade and other receivables, net Trade and other receivables, net Receivables, Net, Current Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Warrants issued (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Chief Executive Officer Chief Executive Officer [Member] Accounts Receivable, Allowance for Credit Loss Accounts Receivable, Allowance for Credit Loss [Table Text Block] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Shares issued under employee stock purchase plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Warrants issued during period (in shares) Stock and Warrants Issued During Period, Shares, Preferred Stock and Warrants Stock and Warrants Issued During Period, Shares, Preferred Stock and Warrants Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Accounts receivable allowances and accruals Accounts Receivable Allowances and Accruals For an unclassified balance sheet, a valuation of sales allowance for receivables due a company that are expected to be uncollectible and accruals. Cash and cash equivalents Beginning of period End of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Cost not yet recognized, amount Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Current assets: Assets, Current [Abstract] Fair Value Measurements Fair Value of Financial Instruments, Policy [Policy Text Block] Royalty rights agreement, measurement input Royalty Agreement, Measurement Input Royalty Agreement, Measurement Input Number of periodic payments Debt Instrument, Number of Periodic Payments Debt Instrument, Number of Periodic Payments Commercial Exploitation Agreement with Indivior Commercial Exploitation Agreement with Indivior [Member] The commercial exploitation agreement with Indivior. Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Product and Service [Domain] Product and Service [Domain] Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Fair Value Disclosures [Abstract] Proceeds from common stock issued under public equity offering, net Proceeds from Issuance Private Offering Proceeds from Issuance Private Offering Warrant Warrant [Member] Security Exchange Name Security Exchange Name Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Income Tax Disclosure [Table] Income Tax Disclosure [Table] Disclosure of information about income taxes. Number of Units Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] State Current State and Local Tax Expense (Benefit) Other Other Assets, Miscellaneous, Noncurrent Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Research and development Research and Development Expense Line of credit facility, accordion feature, net revenue threshold Line of Credit Facility, Accordion Feature, Net Revenue Threshold Line of Credit Facility, Accordion Feature, Net Revenue Threshold Goodwill and Intangible Assets Disclosure [Abstract] Common stock, shares issued (in shares) Common Stock, Shares, Issued Class of warrant or right, exercises (in shares) Class of warrant or right, exercises (in shares) Class of warrant or right, exercises (in shares) Concentrations of risk Concentration Risk, Percentage License and royalty revenue License and Royalty Revenue [Member] The aggregate revenue generated from licensing and royalties. Liability related to the sale of future revenue, net Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Noncurrent Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Noncurrent Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Less: accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Manufacture and supply revenue Manufacture and Supply Revenue [Member] The aggregate revenue generated from manufacture and supply. BRITISH COLUMBIA BRITISH COLUMBIA Number of yearly offering periods Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Offering Periods Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Offering Periods Common stock, shares authorized (in shares) Common Stock, Shares Authorized Class of Warrant or Right [Table] Class of Warrant or Right [Table] Intangible Assets Deferred Tax Assets, Goodwill and Intangible Assets Undistributed Earnings, Basic [Abstract] Undistributed Earnings, Basic [Abstract] Percentage of cash proceeds Repurchase Offer, Percentage of Cash Proceeds Received Repurchase Offer, Percentage of Cash Proceeds Received Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Entity Voluntary Filers Entity Voluntary Filers Interest expense Interest Expense, Nonoperating Total Deferred Income Tax Expense (Benefit) Property and Equipment, Net Property, Plant and Equipment Disclosure [Text Block] Interest expense related to the sale of future revenue Interest Expense, Sale of Future Revenues Interest Expense, Sale of Future Revenues Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Reportable Segment Reportable Segment [Member] Reportable Segment Total outstanding notes Total outstanding notes Long-Term Debt Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Proceeds from warrant exercises Proceeds from Warrant Exercises Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Document Annual Report Document Annual Report Haisco Haisco [Member] Haisco Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Amortization expense Amortization of Intangible Assets Contract with customer, liability Royalty obligations, net Contract with Customer, Liability Payments for financing costs Payments of financing costs Payments of Financing Costs Ex-United States Non-US [Member] Accounting Policies [Abstract] Accounting Policies [Abstract] Unamortized discount Unamortized discount, including Exit Fee Debt Instrument, Unamortized Discount Leasehold improvements Leasehold Improvements [Member] Current Fiscal Year End Date Current Fiscal Year End Date Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Average closing prices period Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Average Closing Prices Period Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Average Closing Prices Period Sale of Future Revenue [Roll Forward] Sale of Future Revenue [Roll Forward] Sale of Future Revenue PEO Name PEO Name Class of warrant or right, outstanding (in shares) Class of Warrant or Right, Outstanding Collaborative Arrangement, Transaction with Party to Collaborative Arrangement Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member] Common Stock issued under public equity offering-ATM Stock Issued During Period, Value, Warrants Exercised Stock Issued During Period, Value, Warrants Exercised Award Type [Domain] Award Type [Domain] Right to sell common stock, value Right to Sell Common Stock, Value Right to Sell Common Stock, Value License agreement term License Agreement Term License agreement term period. Vested restricted stock units (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Stock Compensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Number of licensed commercialized products Number Of Licensed Commercialized Products Number Of Licensed Commercialized Products Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Non-PEO NEO Non-PEO NEO [Member] Audit Information [Abstract] Audit Information Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration] Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration] Additional Paid-in Capital Additional Paid-in Capital [Member] Finance lease, long-term Finance Lease, Liability, Noncurrent Summary of Accounts Receivable, Net Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Royalty Obligations Royalty Obligations [Member] Royalty Obligations Warrants and Rights Note Disclosure [Abstract] Warrants and Rights Note Disclosure [Abstract] Risks and Uncertainties Concentration Risk Disclosure [Text Block] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Title and Position [Domain] Title and Position [Domain] Research and development, amortization period (in years) Research And Development, Amortization Period Research And Development, Amortization Period Less: accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Name Measure Name Entity Interactive Data Current Entity Interactive Data Current Marathon Pangolin Royalty LLC Marathon Pangolin Royalty LLC [Member] Marathon Pangolin Royalty LLC Number of operating segments Number of Operating Segments Number of leases Number of Leases Number of Leases Deferred tax assets: Components of Deferred Tax Assets [Abstract] FDII Deductions Effective Income Tax Rate Reconciliation, FDII, Percent Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Share-based compensation Share-Based Payment Arrangement, Noncash Expense Net deferred tax asset/(liability) Deferred Tax Assets, Net of Valuation Allowance Interest rate Debt Instrument, Interest Rate, Stated Percentage Public equity Public equity [Member] Public equity Accounts Receivable, Allowance for Credit Loss [Roll Forward] Accounts Receivable, Allowance for Credit Loss [Roll Forward] Supplemental disclosures of cash flow information: Supplemental Cash Flow Information [Abstract] Issuance [Axis] Issuance [Axis] Issuance Senior Secured Notes Due 2025 Senior Secured Notes Due 2025 Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member] A debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer. Litigation settlement, period due Litigation Settlement, Amount Award, Period Due Litigation Settlement, Amount Award, Period Due Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Auditor Firm ID Auditor Firm ID Effective tax rate Effective Income Tax Rate Reconciliation, Percent Loss from operations Operating Income (Loss) Market Based Market Based [Member] Market Based Number of reportable segments Number of Reportable Segments Total liabilities and stockholders’ deficit Liabilities and Equity Subsequent Events Subsequent Events [Text Block] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Schedule of Debt Maturities Schedule of Maturities of Long-Term Debt [Table Text Block] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Measurement Input Type [Axis] Measurement Input Type [Axis] Individual: Individual [Axis] Withholding taxes on share-based compensation Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Expected term (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Inventories, net Total inventory Inventory, Net Product and Service [Axis] Product and Service [Axis] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Statement [Line Items] Statement [Line Items] Measurement Input Type [Domain] Measurement Input Type [Domain] Costs and expenses: Operating Expenses [Abstract] Property and Equipment, Net Property, Plant and Equipment [Table Text Block] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Trade receivables and other receivables, net Increase (Decrease) in Accounts and Other Receivables Unamortized deferred debt issuance cost and deferred debt discounts Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Proceeds from issuance of Royalty Rights Agreements Proceeds From Issuance Of Royalty Rights Agreements Proceeds From Issuance Of Royalty Rights Agreements Manufacture and supply Manufacturing and supply [Member] Primary financial statement caption encompassing Manufacturing and supply expense. Minimum Minimum [Member] Royalty Royalty [Member] Adoption Date Trading Arrangement Adoption Date Deferred revenue, net of current portion Contract with Customer, Liability, Noncurrent Market Condition Range One Market Condition Range One [Member] Market Condition Range One Allowance reduction Provision Accounts Receivable, Credit Loss Expense (Reversal) Loans payable, current Line of Credit, Current Number of transactions that reduced debt balance Debt Instrument, Number of Transactions Debt Instrument, Number of Transactions Segments [Axis] Segments [Axis] Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Income taxes at statutory rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Long-term debt, gross Long-Term Debt, Gross Exercise Price Award Exercise Price Schedule of Deferred Tax Assets and Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Arrangement Duration Trading Arrangement Duration Cassie Jung [Member] Cassie Jung Liability for Asset Retirement Obligations Schedule of Asset Retirement Obligations [Table Text Block] Operating loss carryforwards Operating Loss Carryforwards Intangible Assets, Net Goodwill and Intangible Assets Disclosure [Text Block] Stockholders’ deficit: Equity, Attributable to Parent [Abstract] Domestic Tax Jurisdiction Domestic Tax Jurisdiction [Member] Selling expenses: Selling, General and Administrative Expense [Abstract] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] All Individuals All Individuals [Member] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Other (expenses) income Other Nonoperating Income (Expense) Proceeds from exercise of warrants, net Proceeds From Exercise Of Warrants, Net Proceeds From Exercise Of Warrants, Net Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Haisco Pharmaceutical Group Co., Ltd, Upfront Payment Haisco Pharmaceutical Group Co., Ltd, Upfront Payment [Member] Haisco Pharmaceutical Group Co., Ltd, Upfront Payment New Warrants New Warrants [Member] New Warrants Service Based Service Based [Member] Service Based Unusual Risk or Uncertainty [Table] Unusual Risk or Uncertainty [Table] Loss on the extinguishment of debt Extinguishment of Debt, Gain (Loss), Net of Tax Net proceeds from issuance of initial notes, warrants and first offer rights Net Proceeds from Issuance of Initial Notes, Warrants and First Offer Rights The net cash inflow associated with the amount received from issuance of initial notes, warrants and first offer rights. Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Valuation Approach and Technique [Axis] Valuation Approach and Technique [Axis] Contract with customer, receivable, after allowance for credit loss Contract with Customer, Receivable, after Allowance for Credit Loss Vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period Payments for royalty obligations Payments for Royalty Obligations Payments for Royalty Obligations Federal Deferred Federal Income Tax Expense (Benefit) Libervant project expenses Libervant [Member] Libervant Accrued Expenses Schedule of Accrued Liabilities [Table Text Block] Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Impairment of intangible assets, finite-lived Impairment of Intangible Assets, Finite-Lived Payments of stock issuance costs Payments of Stock Issuance Costs Contingencies Commitments and Contingencies Disclosure [Text Block] Prepaid expenses Deferred Tax Liabilities, Prepaid Expenses Impairment, long-lived asset Impairment, Long-Lived Asset, Held-for-Use Measure: Measure [Axis] Share price (in dollars per share) Share Price Common stock issued under equity offering (in shares) Stock Issued During Period, Shares, New Issues Entity Emerging Growth Company Entity Emerging Growth Company Liabilities, fair value disclosure Liabilities, Fair Value Disclosure Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Cosmed Cosmed [Member] Cosmed Equity Component [Domain] Equity Component [Domain] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Entity Shell Company Entity Shell Company Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Comprehensive Loss Comprehensive Income, Policy [Policy Text Block] Capitalized contract cost, net Capitalized Contract Cost, Net Statement [Table] Statement [Table] Counterparty Name [Axis] Counterparty Name [Axis] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Existing Warrants Existing Warrants [Member] Existing Warrants Cash payments for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Option Indexed to Issuer's Equity, Type [Domain] Option Indexed to Issuer's Equity, Type [Domain] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Total current assets Assets, Current Grant date fair value Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants, Grant Date Fair Value The fair market value of nonvested equity-based awards on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan) as of grant date. Market Conditions [Axis] Market Conditions [Axis] Market Conditions Trade receivables Accounts Receivable, before Allowance for Credit Loss Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Senior Notes Senior Notes [Member] Exercisable at end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number 2027 Long-Term Debt, Maturity, Year Three Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Co-development and research fees Co-Development and Research Fees [Member] The aggregate revenue generated from Co-development and research fees. Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Neurelis, Inc. v. Aquestive Therapeutics, Inc. Neurelis, Inc. v. Aquestive Therapeutics, Inc. [Member] Neurelis, Inc. v. Aquestive Therapeutics, Inc. Income Taxes Income Tax Disclosure [Text Block] 2028 Lessee, Operating Lease, Liability, to be Paid, Year Four Summary of Revenue Revenue from External Customers by Products and Services [Table Text Block] Royalty Right Agreements Royalty Right Agreements [Member] Royalty Right Agreements Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Accrued expenses Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals Equity Distribution Agreement Equity Distribution Agreement [Member] Equity Distribution Agreement Credit Facility [Axis] Credit Facility [Axis] Selling and Marketing Expense Selling Expense Warrants, $0.96 Exercise Price Warrants, $0.96 Exercise Price [Member] Warrants, $0.96 Exercise Price Fair value Long-Term Debt, Fair Value Entity Registrant Name Entity Registrant Name Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Anaphylm project expenses Anaphylm [Member] Anaphylm State Deferred State and Local Income Tax Expense (Benefit) Fair Value as of Grant Date Award Grant Date Fair Value Customer Concentration Risk Customer Concentration Risk [Member] Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Fair Value, Inputs, Level 2 Fair Value, Inputs, Level 2 [Member] Geographical [Domain] Geographical [Domain] Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Common Stock issued under public equity offering Stock Issued During Period, Value, New Issues Asset Retirement Obligation Disclosure [Abstract] Asset Retirement Obligation Disclosure [Abstract] Restatement Determination Date: Restatement Determination Date [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Title of 12(b) Security Title of 12(b) Security Concentration Risk Type [Axis] Concentration Risk Type [Axis] Common stock, 0.001 par value. Authorized 250,000,000 shares; 91,413,742 and 68,533,085 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively Common Stock, Value, Issued Document Financial Statement Error Correction Document Financial Statement Error Correction [Flag] Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Asset retirement obligation Balance at beginning of period Balance at ending of period Asset Retirement Obligation Severance costs, monthly payment, duration Severance Costs Monthly Payment, Duration Severance Costs Monthly Payment, Duration State income tax Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Exercisable at end of period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Other Deferred Tax Assets, Other Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Market Condition Range Six Market Condition Range Six [Member] Market Condition Range Six Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Concentration Risk [Line Items] Concentration Risk [Line Items] Finished goods Inventory, Finished Goods, Gross Deferred tax liabilities Deferred Tax Liabilities, Gross Valuation Approach and Technique [Domain] Valuation Approach and Technique [Domain] Basic (in dollars per share) Earnings Per Share, Basic Sales commissions and fees Sales Commissions and Fees Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Non-cash investing activities: capital expenditures in accounts payable Capital Expenditures Incurred but Not yet Paid Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Monetization Agreement Monetization Agreement [Member] Monetization Agreement Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Total current liabilities Liabilities, Current Securities Purchase Agreement Securities Purchase Agreement [Member] Securities Purchase Agreement Share-based payment arrangement, nonvested award, option, cost not yet recognized, amount Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Concentration of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Over-Allotment Option Over-Allotment Option [Member] Other Other [Member] Other License Agreement with Sunovion Pharmaceuticals, Inc Milestones License Agreement with Sunovion Pharmaceuticals, Inc Milestones [Member] The license agreement made with sunovion pharmaceuticals, inc. milestones. Market Condition Range Three Market Condition Range Three [Member] Market Condition Range Three Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Exercise price of warrants (in usd per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Revenues Revenues Share-Based Compensation Share-Based Payment Arrangement [Text Block] General & Administrative expenses: General and Administrative Expense [Abstract] Entity Address, City or Town Entity Address, City or Town Payments / credits Accounts Receivable, Allowance for Credit Loss, Recovery Leases Lessee, Leases [Policy Text Block] Summary of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Total share-based compensation expenses Share-Based Payment Arrangement, Expense Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Loss Contingencies [Table] Loss Contingencies [Table] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Schedule of Finite Lived - Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Proceeds from shares issued under employee stock purchase plan Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Excluding Option Exercised Proceeds from debt, contingent on additional milestones Contingent Monetization Agreement, Milestone Payment Contingent Monetization Agreement, Milestone Payment Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Foreign Tax Jurisdiction Foreign Tax Jurisdiction [Member] Warrants, $5.38 Exercise Price Warrants, $5.38 Exercise Price [Member] Warrants, $5.38 Exercise Price Revenues and Trade Receivables, Net Revenue from Contract with Customer [Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Other Other Accrued Liabilities, Current Current portion of liability related to sale of future revenue Liabilities, Sale of Future Royalties, Current Liabilities, Sale of Future Royalties, Current Unamortized discount, net Debt Instrument, Unamortized Discount (Premium), Net Document Period End Date Document Period End Date Sale of Stock [Axis] Sale of Stock [Axis] Put Option Put Option [Member] Total lease payments Lessee, Operating Lease, Liability, to be Paid Equity instruments other than options, nonvested, number (in shares) Unvested, at beginning of period (in shares) Unvested, at end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Insider Trading Arrangements [Line Items] 2027 Lessee, Operating Lease, Liability, to be Paid, Year Three Contract with customer, liability, revenue recognized Contract with Customer, Liability, Revenue Recognized Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Document Transition Report Document Transition Report Warrants, $4.25 Exercise Price Warrants, $4.25 Exercise Price [Member] Warrants, $4.25 Exercise Price Customer [Domain] Customer [Domain] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Entity Current Reporting Status Entity Current Reporting Status Accumulated Deficit Retained Earnings [Member] Amortization of issuance costs Amortization of Debt Issuance Costs Summary of Sales-related Allowances Schedule of Accounts Receivable Allowances [Table Text Block] Tabular disclosure of valuation of sales allowance for receivables due a company that are expected to be uncollectible including a rollforward of the balance. Restricted Stock Units Restricted Stock Units (RSUs) [Member] Vested or expected to vest at end of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested or expected to Vest, Aggregate Intrinsic Value The aggregate intrinsic value of options vested or expected to vest. Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Executive Category: Executive Category [Axis] Schedule of Components of Income Tax Expense (Benefit) Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration] Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration] Statement of Income Location, Balance [Domain] Statement of Income Location, Balance [Domain] Company Selected Measure Name Company Selected Measure Name Manufactured Product, Other [Member]